Comparar métodos
Revisa los métodos seleccionados uno junto a otro; las filas que difieren aparecen resaltadas.
| Evaluación de Impacto Contrafactual con Efectos de Tratamiento Heterogéneos× | Emparejamiento por Puntuación de Propensión× | |
|---|---|---|
| Campo≠ | Inferencia causal | Estadística para la investigación |
| Familia≠ | Regression model | Process / pipeline |
| Año de origen≠ | 2010s | 1983 |
| Autor original≠ | Cerulli (2010) for CIE framework; Athey & Wager (2019) for causal forest-based CATE within CIE | Paul Rosenbaum and Donald Rubin |
| Tipo≠ | Quasi-experimental causal inference with subgroup heterogeneity | Method |
| Fuente seminal≠ | Cerulli, G. (2010). Modelling and measuring the effect of public subsidies on business R&D: A critical review of the econometric literature. Economic Record, 86(274), 421-449. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Alias≠ | HTE-CIE, heterogeneous CIE, CATE-based counterfactual evaluation, subgroup counterfactual impact evaluation | PSM, propensity score weighting, covariate balance |
| Relacionados≠ | 4 | 3 |
| Resumen≠ | Heterogeneous Treatment Effect Counterfactual Impact Evaluation (HTE-CIE) extends standard counterfactual impact evaluation by estimating how the causal effect of a policy or intervention varies across subgroups defined by pre-treatment characteristics. Rather than reporting a single average treatment effect, it maps the Conditional Average Treatment Effect (CATE) across the covariate space, revealing who benefits most or least from an intervention. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateConjunto de datos ↗ |
|
|